Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding ...Middle East

PR Newswire - News
Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding
OSAKA, Japan, Oct. 9, 2024 /PRNewswire/ -- Alpha Fusion, Inc. (CEO: Sunao Fujioka, headquartered in Kita-ku, Osaka), has raised a total of ¥1.02 billion through a Series B funding round. The round was led by SBI Investment Co., Ltd. and OSAKA University Venture Capital, with participation...

Hence then, the article about alpha fusion accelerates astatine based drug discovery with series b funding was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News